Survey of Ophthalmology
Volume 46, Issue 1 , Pages 56-58 , July 2001

Disk Edema and Cranial MRI Optic Nerve Enhancement: How Long is Too Long?

  • Michael S Vaphiades, DO

      Affiliations

    • Corresponding Author InformationReprint address: Michael S. Vaphiades, DO, Harvey & Bernice Jones Eye Institute, Department of Ophthalmology, University of Arkansas for Medical Sciences, 4301 West Markham, Mail Slot 523, Little Rock, Arkansas 72205-7199 USA

References 

  1. Optic Neuritis Study Group . The 5-year risk of MS after optic neuritis. Experience of the optic neuritis treatment trial. Neurology. 1997;49:1404–1413
  2. Optic Neuritis Study Group . The clinical profile of optic neuritis. Experience of the Optic Neuritis Treatment Trial. Arch Ophthalmol. 1991;109:1673–1678
  3. Beck RW. Optic neuritis. In:  Miller NR,  Newman NJ editor. Walsh & Hoyt's Clinical Neuro-Ophthalmology, Vol I. Baltimore: Williams & Wilkins; 1998;p. 599–647ed 5,
  4. Beck RW, Arrington J, Murtagh FR, et al.  Brain magnetic resonance imaging in acute optic neuritis. Experience of the Optic Neuritis Study Group. Arch Neurol. 1993;50:841–846
  5. Beck RW, Cleary PA, Backlund JC. The course of visual recovery after optic neuritis. Experience of the Optic Neuritis Treatment Trial. Ophthalmology. 1994;101:1771–1778
  6. Brazis PW, Lee AG. Optic disk edema with a macular star. Mayo Clin Proc. 1996;71:1162–1166
  7. Gass A, Barker GJ, MacManus D, et al.  High resolution magnetic resonance imaging of the anterior visual pathway in patients with optic neuropathies using fast spin echo and phased array local coils. J Neurol Neurosurg Psychiatry. 1995;58:562–569
  8. Guy J, Mancuso A, Quisling RG, et al.  Gadolinium-DTPA-enhanced magnetic resonance imaging in optic neuropathies. Ophthalmology. 1990;97:592–599discussion 599–600
  9. Guy J, Mao J, Bidgood WD, et al.  Enhancement and demyelination of the intraorbital optic nerve. Fat suppression magnetic resonance imaging. Ophthalmology. 1992;99:713–719
  10. Jacobs LD, Beck RW, Simon JH, et al.  Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. N Engl J Med. 2000;343:898–904
  11. Keltner JL, Johnson CA, Spurr JO, Beck RW. Baseline visual field profile of optic neuritis. The experience of the optic neuritis treatment trial. Optic Neuritis Study Group. Arch Ophthalmol. 1993;111:231–234
  12. Lee DH, Simon JH, Szumowski J, et al.  Optic neuritis and orbital lesions (lipid-suppressed chemical shift MR imaging). Radiology. 1991;179:543–546
  13. Lindblom B, Truwit CL, Hoyt WF. Optic nerve sheath meningioma. Definition of intraorbital, intracanalicular, and intracranial components with magnetic resonance imaging. Ophthalmology. 1992;99:560–566
  14. Sarkies NJ. Optic nerve sheath meningioma (diagnostic features and therapeutic alternatives). Eye. 1987;1:597–602
  15. Sibony PA, Krauss HR, Kennerdell JS, et al.  Optic nerve sheath meningiomas. Clinical manifestations. Ophthalmology. 1984;91:1313–1326
  16. Wright JE, McNab AA, McDonald WI. Primary optic nerve sheath meningioma. Br J Ophthalmol. 1989;73:960–966

☆ The author has no proprietary or commercial interest in any product or concept discussed in this article.

PII: S0039-6257(01)00226-0

Survey of Ophthalmology
Volume 46, Issue 1 , Pages 56-58 , July 2001

Article Tools

* Image Usage & Resolution